zika

Congress Passes Zika Funding Bill

Congress passed and President Obama signed a 10-week continuing resolution, which includes $1.1 billion for Zika virus research.
Read

ASM Acts to Counter Zika Virus Outbreak

The emerging threat of Zika virus infection.
Read

ASM Urges Action to Combat Zika Emergency

Current events linked to the Zika virus make aggressive public health actions and funding to combat this emerging infectious disease more crucial than ever.
Read
Become a member today!
JOIN ASM
Submit Abstracts for Biothreats 2017
SUBMIT
Antibacterial Development Conference
REGISTER

bonomo robertDr. Bonomo's laboratory studies the genetic and biochemical basis of beta-lactam resistance mediated by beta-lactamases and penicillin binding proteins in Klebsiella pneumoniae, Pseudomonas aeruginosa, and Acinetobacter baumannii. To these ends he is interested in beta-lactam antibiotics and beta-lactamase inhibitors as novel therapeutics. He has also explored structure-function relationships of SHV and KPC beta-lactamases with BLIP, the beta-Lactamase Inhibitory Protein. Recent work is focused on novel approaches to understanding the molecular epidemiology and rapidly detecting multidrug-resistant (MDR) Acinetobacter baumannii and carbapenem resistant Klebsiella pneumoniae. In addition, he is interested in the complex genetic background and genome sequence of MDR A. baumannii, extended-spectrum beta-lactamase and carbapenem resistant K. pneumoniae. Dr. Bonomo's lab also seeks to apply molecular diagnostics to define the transmissibility and resistance profile of S. aureus.

TPL_asm2013_SEARCH

91087